RNF112 and glioma: Our genetic analysis showed that expression levels of Znf179 genes are highly correlated with prognosis and survival rates of patients with different glioma grades, further supporting that Znf179 may serve as a potential prognostic biomarker to allow the prediction of therapeutic prognosis and survival rates of glioma patients.